相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring human genomic diversity with gnomAD
Linda Koch
NATURE REVIEWS GENETICS (2020)
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries
Vincent Carbonnier et al.
SCIENTIFIC REPORTS (2020)
The Missing Diversity in Human Genetic Studies
Giorgio Sirugo et al.
CELL (2019)
A quantitative model to predict pathogenicity of missense variants in the TP53 gene
Cristina Fortuno et al.
HUMAN MUTATION (2019)
Response to: Concern regarding classification of germlineTP53 variants as likely pathogenic
Kelvin C. de Andrade et al.
HUMAN MUTATION (2019)
Concern regarding classification of germline TP53 variants as likely pathogenic
D. Gareth Evans et al.
HUMAN MUTATION (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis
Kelvin C. de Andrade et al.
HUMAN MUTATION (2019)
Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants
Cristina Fortuno et al.
HUMAN MUTATION (2018)
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
J. Malcikova et al.
LEUKEMIA (2018)
A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation
Eran Kotler et al.
MOLECULAR CELL (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Quantitative Missense Variant Effect Prediction Using Large-Scale Mutagenesis Data
Vanessa E. Gray et al.
CELL SYSTEMS (2018)
Mutational processes shape the landscape of TP53 mutations in human cancer
Andrew O. Giacomelli et al.
NATURE GENETICS (2018)
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Kurt Engeland
CELL DEATH AND DIFFERENTIATION (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
The SWISS-MODEL Repository-new features and functionality
Stefan Bienert et al.
NUCLEIC ACIDS RESEARCH (2017)
Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history
Kelvin Cesar de Andrade et al.
HUMAN MUTATION (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging A Meta-analysis
Mandy L. Ballinger et al.
JAMA ONCOLOGY (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO
Gang Peng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
Bernard Leroy et al.
CANCER RESEARCH (2017)
A functionally significant SNP in TP53 and breast cancer risk in African-American women
Maureen E. Murphy et al.
NPJ BREAST CANCER (2017)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M. Ioannidis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
Matthew Jennis et al.
GENES & DEVELOPMENT (2016)
HGVS Recommendations for the Description of Sequence Variants: 2016 Update
Johan T. den Dunnen et al.
HUMAN MUTATION (2016)
dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
Xiaoming Liu et al.
HUMAN MUTATION (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
Martin Fischer et al.
NUCLEIC ACIDS RESEARCH (2016)
Predicting protein thermal stability changes upon point mutations using statistical potentials: Introducing HoTMuSiC
Fabrizio Pucci et al.
SCIENTIFIC REPORTS (2016)
Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance
Nicholas T. Woods et al.
NPJ GENOMIC MEDICINE (2016)
Defining mutation and polymorphism in the era of personal genomics
Roshan Karki et al.
BMC MEDICAL GENOMICS (2015)
TP53: an oncogene in disguise
T. Soussi et al.
CELL DEATH AND DIFFERENTIATION (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Single Nucleotide Differences (SNDs) Continue to Contaminate the dbSNP Database With Consequences for Human Genomics and Health
Jonathan W. Arthur et al.
HUMAN MUTATION (2015)
PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants
Abhishek Niroula et al.
PLOS ONE (2015)
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Fran Supek et al.
CELL (2014)
Genotype Misclassification in Genetic Association Studies of the rs1042522 TP53 (Arg72Pro) Polymorphism: A Systematic Review of Studies of Breast, Lung, Colorectal, Ovarian, and Endometrial Cancer
Issa J. Dahabreh et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors
Karolina Edlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants
Alon Keinan et al.
SCIENCE (2012)
Interaction of the p53 DNA-Binding Domain with Its N-Terminal Extension Modulates the Stability of the p53 Tetramer
Eviatar Natan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Structure of the p53 Transactivation Domain in Complex with the Nuclear Receptor Coactivator Binding Domain of CREB Binding Protein
Chul Won Lee et al.
BIOCHEMISTRY (2010)
Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations
Sarah E. Flanagan et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2010)
Single Nucleotide Differences (SNDs) in the dbSNP Database May Lead to Errors in Genotyping and Haplotyping Studies
Lucia Musumeci et al.
HUMAN MUTATION (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs
Malka Kitayner et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Deep resequencing reveals excess rare recent variants consistent with explosive population growth
Alex Coventry et al.
NATURE COMMUNICATIONS (2010)
Automated inference of molecular mechanisms of disease from amino acid substitutions
Biao Li et al.
BIOINFORMATICS (2009)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast
D. Grochova et al.
ONCOGENE (2008)
Improving sequence variant descriptions in mutation Databases and literature using the mutalyzer sequence variation nomenclature checker
Martin Wildeman et al.
HUMAN MUTATION (2008)
Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population
Hidetaka Yamada et al.
CARCINOGENESIS (2007)
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structural basis of DNA recognition by p53 tetramers
Malka Kitayner et al.
MOLECULAR CELL (2006)
P53C-terminal phosphorylation by CHM and CHK2 participates in the regulation of DNA-Damage-induced C-terminal acetylation
YH Ou et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations
T Soussi et al.
HUMAN MUTATION (2005)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
M Schmidt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence
A Inga et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
RC Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
P Campomenosi et al.
ONCOGENE (2001)
分享论文
